Allergan Urges 1st Circ. To Reverse Asacol Class Cert.

Law360, Washington (February 26, 2018, 9:35 PM EST) -- Allergan PLC urged the First Circuit on Friday to reverse the certification of a class of buyers of an anti-inflammatory drug, accusing the putative class of “bootstrapping” claims from purchasers of the drug in just four states to bring claims under dozens of other states’ antitrust laws.

A Massachusetts federal judge improperly certified a class of union-sponsored health insurers to bring claims under the antitrust laws in 26 jurisdictions, even though the class representatives have standing in just four states at most, Allergan and its subsidiary...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.